Market Closed -
Other stock markets
|
Pre-market 07:00:15 am | |||
73.01 USD | +0.83% | 73.12 | +0.14% |
12:34pm | Gilead Sciences in Exclusive License for Xilio Tumor-Activated IL-12 Program | DJ |
Mar. 22 | Gilead Sciences Completes $4.3 Billion Cymabay Acquisition | MT |
- Stock
- Equities
- Stock Gilead Sciences, Inc. - Nasdaq
- News Gilead Sciences, Inc.